Status:
COMPLETED
HYPONCO - Hypoxia in Brain Tumors
Lead Sponsor:
University Hospital, Caen
Conditions:
Anaplastic Glioma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Background : In malignant gliomas, hypoxia is associated with tumour angiogenesis and tumour progression. This multidisciplinary preclinical and clinical project aims to validate the use of 18F-FMISO...
Eligibility Criteria
Inclusion
- adults aged \>= 18 years
- KPS \>= 70%
- must have the understanding and ability to sign an informed consent document
- be male or non-pregnant
- non-lactating females
- Patients who are fertile must agree to use an effective method of contraception during participation in the study
- the following laboratory results : absolute neutrophil count \>= 1500 cells/µl, platelet count \>= 100,000 cells/µl, SGOT \<= 2.5 x ULN, serum creatinine \<= 1.5 x ULN
Exclusion
- contraindication to surgery
- concomitant radio-, chemo-, or immunotherapy
- known diagnosis of Human Immunodeficiency Virus (HIV) infection
- patient with hepatitis B or C
- diabetic patient
- patient with kidney or liver deficiency
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01200134
Start Date
October 1 2010
End Date
July 1 2012
Last Update
November 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen University Hospital
Caen, France, 14033